Optimizing Mavenclad Prior Authorization for Orthopedics with Klivira

Navigating Mavenclad prior authorization for orthopedics requires a nuanced approach, particularly when managing patients with multiple comorbidities. Klivira streamlines the PA process for orthopedic interventions in these complex patient populations.

Orthopedic practices frequently encounter patients with diverse medical histories, including those undergoing treatment for chronic conditions like Multiple Sclerosis (MS). While Mavenclad (cladribine) is a disease-modifying therapy for MS, its presence in a patient's profile introduces specific considerations for orthopedic prior authorization, impacting everything from advanced imaging to surgical interventions. Efficiently managing these complex PA requirements is critical for timely patient care and revenue cycle integrity.

Understanding Mavenclad in the Orthopedic Patient Context

Mavenclad (cladribine) is an oral nucleoside analog indicated for the treatment of relapsing forms of multiple sclerosis (MS). Orthopedic practices frequently manage patients with MS who may be receiving Mavenclad. While orthopedists do not prescribe Mavenclad, understanding its implications, particularly regarding immunosuppression, is crucial when seeking prior authorization for orthopedic procedures, imaging, or durable medical equipment (DME) for these patients. The intersection primarily involves managing comorbidities and ensuring comprehensive documentation for orthopedic interventions.

Key Orthopedic PA Categories with Comorbidity Considerations

Major Joint Replacement: Patients with MS may require joint replacement due to immobility-related degeneration or falls. PA documentation must account for overall health status and surgical risk.
Spine Surgery: MS can present with gait disturbances or spasticity, potentially leading to spinal issues. PA for spine surgery needs thorough neurological assessment and comorbidity documentation.
Advanced Imaging (MRI/CT): Essential for diagnosing orthopedic conditions, but considerations for patients on disease-modifying therapies may arise, requiring comprehensive clinical context.
DME and Bracing: Mobility aids and braces are common for MS patients, requiring PA that integrates their neurological status and functional limitations.
Physical/Occupational Therapy: Often prescribed for MS patients for gait and strength, requiring PA that considers their comprehensive care plan and functional goals.

Documentation for Orthopedic PAs in Mavenclad Patients

For patients on Mavenclad, orthopedic prior authorization documentation must extend beyond standard musculoskeletal criteria. This includes a comprehensive medical history detailing the MS diagnosis, current treatment regimen (including Mavenclad), and any related comorbidities. Payers may scrutinize the patient's overall health status, potential immune system impacts of Mavenclad, and how these factors influence the safety and efficacy of proposed orthopedic interventions. Documentation of neurological status, functional limitations related to MS, and coordination with neurology teams can strengthen PA submissions.

Common Denial Factors in Complex Orthopedic Cases

Insufficient conservative-care trial: Despite MS, payers still require documentation of appropriate conservative measures for orthopedic conditions, as per AAOS Clinical Practice Guidelines.
Comorbidity-related surgical risk: Payers may deny based on perceived increased surgical risk due to MS or its treatments, requiring robust clinical justification.
Lack of comprehensive medical history: Failure to adequately document the patient's MS diagnosis and Mavenclad treatment in the orthopedic PA request is a common pitfall.
Imaging-symptom correlation gaps: Especially critical when MS symptoms might overlap with orthopedic complaints, necessitating clear differentiation of pathology.
Site-of-service mismatch: Payer policy directing procedures to specific settings (e.g., ASC vs. hospital) may lead to denials if not adhered to, regardless of patient's underlying conditions.

Klivira's Role in Streamlining Complex Orthopedic PAs

Klivira's platform is designed to navigate the complexities of prior authorization for orthopedic practices, including those managing patients with chronic conditions like MS. Our system leverages EMR integration (e.g., SMART on FHIR) to automatically extract relevant patient data, including medication lists and comorbidity documentation, often required for comprehensive PA submissions. This capability aids in building robust cases for orthopedic procedures, advanced imaging, or DME, ensuring that the full clinical picture of a patient on Mavenclad is presented to payers. We facilitate the orchestration of multi-step PA cascades, common in orthopedics, while accounting for the unique needs of patients with complex medical histories.

Integrating Klivira for Enhanced Prior Authorization Workflows

Klivira's integration capabilities support orthopedic practices in automating prior authorization across diverse payer channels and benefit managers. By connecting with EMRs, our platform reduces manual data entry and improves the accuracy of PA requests, addressing high PA volumes per surgeon practice. This allows prior authorization coordinators to focus on critical clinical details and peer-to-peer reviews, rather than administrative tasks. The result is a more efficient PA workflow, minimizing pre-operative scheduling pressure and reducing delays for patients requiring orthopedic care, including those on therapies like Mavenclad.

Frequently asked questions

How does Klivira handle PA for orthopedic procedures when a patient is on Mavenclad?

Klivira's platform automates data extraction from EMRs, compiling a comprehensive patient profile that includes medication lists like Mavenclad and relevant medical history. This ensures that orthopedic PA requests for procedures, imaging, or DME accurately reflect the patient's full clinical picture, aiding in the justification of medical necessity to payers.

What specific documentation is needed for orthopedic PAs in patients with MS on Mavenclad?

Beyond standard orthopedic documentation (e.g., failed conservative care, imaging), specific requirements for patients on Mavenclad may include detailed neurological evaluations, a complete medication list, and assessment of potential immunosuppression. Klivira helps consolidate these diverse documentation points for a complete submission.

Can Klivira help with P2P reviews for complex orthopedic cases involving comorbidities?

Yes, Klivira supports the prior authorization workflow through the entire lifecycle, including facilitating peer-to-peer (P2P) review scheduling and providing the necessary clinical documentation to support the orthopedic surgeon's discussion with the payer's medical director for complex cases involving comorbidities.

Does Klivira integrate with EMRs to pull medication lists like Mavenclad?

Klivira integrates directly with major EMR systems using standards like SMART on FHIR. This capability allows our platform to automatically query and pull critical patient data, including active medication lists, problem lists, and vitals, ensuring that treatments like Mavenclad are captured in PA submissions without manual effort.

How does Klivira address common orthopedic PA denials for patients with chronic conditions?

Klivira addresses common orthopedic PA denials by ensuring comprehensive documentation, aligning requests with payer-specific policies, and identifying potential gaps before submission. For patients with chronic conditions, our system helps flag requirements related to comorbidities, such as adequate conservative care trials and justification of surgical risk, to proactively mitigate denial reasons.